Bridgecreek Investment Management LLC boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,835 shares of the healthcare conglomerate’s stock after buying an additional 860 shares during the quarter. UnitedHealth Group makes up approximately 1.6% of Bridgecreek Investment Management LLC’s portfolio, making the stock its 22nd biggest position. Bridgecreek Investment Management LLC’s holdings in UnitedHealth Group were worth $7,018,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Dorsey & Whitney Trust CO LLC raised its position in shares of UnitedHealth Group by 25.0% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 16,798 shares of the healthcare conglomerate’s stock worth $3,115,000 after acquiring an additional 3,357 shares in the last quarter. TCI Wealth Advisors Inc. raised its position in shares of UnitedHealth Group by 1.5% in the 2nd quarter. TCI Wealth Advisors Inc. now owns 1,609 shares of the healthcare conglomerate’s stock worth $298,000 after acquiring an additional 23 shares in the last quarter. Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $209,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $114,000. Finally, Letko Brosseau & Associates Inc. raised its position in shares of UnitedHealth Group by 3.4% in the 2nd quarter. Letko Brosseau & Associates Inc. now owns 3,824 shares of the healthcare conglomerate’s stock worth $709,000 after acquiring an additional 124 shares in the last quarter. 86.78% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the transaction, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the completion of the transaction, the director now owns 76,637 shares in the company, valued at approximately $18,881,824.06. The disclosure for this sale can be found here. Insiders have sold a total of 77,015 shares of company stock valued at $17,879,199 over the last three months. Corporate insiders own 0.89% of the company’s stock.
Several research firms have recently weighed in on UNH. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $254.00 price objective for the company in a research report on Wednesday. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 8th. Barclays started coverage on UnitedHealth Group in a research report on Thursday, March 8th. They issued an “overweight” rating and a $265.00 target price for the company. Finally, Argus boosted their target price on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 18th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $244.62.
Shares of UnitedHealth Group stock opened at $222.82 on Thursday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $217,772.55, a P/E ratio of 20.80, a price-to-earnings-growth ratio of 1.31 and a beta of 0.74. UnitedHealth Group Inc has a twelve month low of $162.74 and a twelve month high of $250.79.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $2.11 EPS. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 28.01%.
WARNING: “Bridgecreek Investment Management LLC Buys 860 Shares of UnitedHealth Group Inc (UNH)” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/03/22/bridgecreek-investment-management-llc-buys-860-shares-of-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.